The Toronto-based company began trading on the US exchange on January 9. The newly-christened firm will be represented by CEO Raza Bokhari, along with members of the board, leadership team, early investors and others.
“It will indeed be a unique privilege for me to ring the opening bell at Nasdaq to commence trading in the presence of FSD Pharma’s extended family and friends," Bokhari said in a statement. "The recent listing of our Class B Subordinate Voting Shares on Nasdaq has included us in a select group of 12 Canadian-domiciled cannabis companies that trade on a major U.S. exchange.”
In fact, FSD is the first company trading on the Candian Securities Exchange to ever achieve a Nasdaq listing, according to a tweet from the exchange last week.
CSE congratulates @FsdPharma for their recent listing on the @Nasdaq Capital Market under the symbol $HUGE - this marks the first time a CSE issuer has achieved a dual listing on NASDAQ! pic.twitter.com/bvHPDk5HFP— CSE (@CSE_News) January 10, 2020
Bokhari, for his part, is ready to separate FSD from the pack.
“I am, however, very hopeful that sooner rather than later we will be placed in a league of our own as we continue to demonstrate that the primary thrust of our business is to focus on conducting clinical trials on synthetic compounds with anti-inflammatory properties that target the CB2 receptor of the endocannabinoid system of the human body," he added.
The bell-ringing ceremony will be webcast on the Nasdaq’s website and livestreamed on Facebook beginning at 9:20 am ET.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel